Géraldine Lens, Niloefar Ahmadi Bidakhvidi, Vincent Vandecaveye, Steven Grauwels, Annouschka Laenen, Wies Deckers, Ronald Peeters, Raphaëla C Dresen, Jeroen Dekervel, Chris Verslype, Kristiaan Nackaerts, Paul M Clement, Eric Van Cutsem, Michel Koole, Karolien Goffin, Koen Van Laere, Christophe M Deroose
BACKGROUND: Somatostatin receptor (SSTR) positron emission tomography (PET) is a cornerstone of neuroendocrine tumor (NET) management. Hybrid PET/magnetic resonance imaging (MRI) is now available for NET-imaging, next to PET/computed tomography (CT). OBJECTIVES: To determine whether CT or MRI is the best hybrid partner for [68 Ga]Ga-DOTATATE PET. DESIGN: Monocentric, prospective study. METHODS: Patients received a same-day [68 Ga]Ga-DOTATATE PET/CT and subsequent PET/MRI, for suspicion of NET, (re)staging or peptide receptor radionuclide therapy-selection...
2023: Therapeutic Advances in Medical Oncology